Robin A. Nadar

588 total citations
10 papers, 277 citations indexed

About

Robin A. Nadar is a scholar working on Radiology, Nuclear Medicine and Imaging, Oncology and Biomedical Engineering. According to data from OpenAlex, Robin A. Nadar has authored 10 papers receiving a total of 277 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Radiology, Nuclear Medicine and Imaging, 5 papers in Oncology and 4 papers in Biomedical Engineering. Recurrent topics in Robin A. Nadar's work include Radiopharmaceutical Chemistry and Applications (6 papers), Bone health and treatments (4 papers) and Bone Tissue Engineering Materials (3 papers). Robin A. Nadar is often cited by papers focused on Radiopharmaceutical Chemistry and Applications (6 papers), Bone health and treatments (4 papers) and Bone Tissue Engineering Materials (3 papers). Robin A. Nadar collaborates with scholars based in Netherlands, Italy and Germany. Robin A. Nadar's co-authors include Sander C.G. Leeuwenburgh, Nicola Margiotta, Michele Iafisco, Jeroen J.J.P. van den Beucken, Lorenzo Degli Esposti, Otto C. Boerman, Barbara Palazzo, Holger Stephan, Ondřej Sedláček and Martin Hrubý and has published in prestigious journals such as Scientific Reports, ACS Applied Materials & Interfaces and Nanoscale.

In The Last Decade

Robin A. Nadar

10 papers receiving 255 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Robin A. Nadar Netherlands	9	124	75	59	58	43	10	277
Suyene Rocha Pinto Brazil	12	130 1.0×	32 0.4×	93 1.6×	54 0.9×	100 2.3×	20	345
Alessandra Curci Italy	9	46 0.4×	98 1.3×	26 0.4×	18 0.3×	19 0.4×	11	201
Ignacio Garcı́a-Alonso Spain	11	129 1.0×	30 0.4×	108 1.8×	22 0.4×	30 0.7×	44	362
Chenjun Huang China	10	70 0.6×	36 0.5×	42 0.7×	14 0.2×	24 0.6×	28	269
Haoran Ji China	5	92 0.7×	40 0.5×	82 1.4×	22 0.4×	38 0.9×	6	331
Mingze Xu China	5	135 1.1×	25 0.3×	99 1.7×	16 0.3×	110 2.6×	15	380
Bhuvaneswari Koneru United States	8	75 0.6×	24 0.3×	93 1.6×	20 0.3×	83 1.9×	9	258
Xiaozhi Zhang China	9	78 0.6×	44 0.6×	102 1.7×	22 0.4×	45 1.0×	17	331
Sara Khademi Iran	10	227 1.8×	28 0.4×	128 2.2×	65 1.1×	82 1.9×	32	423
Kenji Tazawa Japan	11	179 1.4×	30 0.4×	188 3.2×	25 0.4×	19 0.4×	40	420

Countries citing papers authored by Robin A. Nadar

Since Specialization

Citations

This map shows the geographic impact of Robin A. Nadar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robin A. Nadar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robin A. Nadar more than expected).

Fields of papers citing papers by Robin A. Nadar

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robin A. Nadar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robin A. Nadar. The network helps show where Robin A. Nadar may publish in the future.

Co-authorship network of co-authors of Robin A. Nadar

This figure shows the co-authorship network connecting the top 25 collaborators of Robin A. Nadar. A scholar is included among the top collaborators of Robin A. Nadar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robin A. Nadar. Robin A. Nadar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

10 of 10 papers shown

Nadar, Robin A., Lorenzo Degli Esposti, Barbara Palazzo, et al.. (2020). Platinum-loaded, selenium-doped hydroxyapatite nanoparticles selectively reduce proliferation of prostate and breast cancer cells co-cultured in the presence of stem cells. Journal of Materials Chemistry B. 8(14). 2792–2804. 45 indexed citations

Nadar, Robin A., Kambiz Farbod, Lukas Schlatt, et al.. (2020). Targeting of radioactive platinum-bisphosphonate anticancer drugs to bone of high metabolic activity. Scientific Reports. 10(1). 5889–5889. 44 indexed citations

Nadar, Robin A., Nandini Asokan, Lorenzo Degli Esposti, et al.. (2020). Preclinical evaluation of platinum-loaded hydroxyapatite nanoparticles in an embryonic zebrafish xenograft model. Nanoscale. 12(25). 13582–13594. 15 indexed citations

Nadar, Robin A., Gerben M. Franssen, Egbert Oosterwijk, et al.. (2020). Bone tumor–targeted delivery of theranostic 195mPt-bisphosphonate complexes promotes killing of metastatic tumor cells. Materials Today Bio. 9. 100088–100088. 19 indexed citations

Palazzo, Barbara, Lorenzo Degli Esposti, Alessio Adamiano, et al.. (2020). Selenium-doped hydroxyapatite nanoparticles for potential application in bone tumor therapy. Journal of Inorganic Biochemistry. 215. 111334–111334. 43 indexed citations

Crone, Barbara, Lukas Schlatt, Robin A. Nadar, et al.. (2019). Quantitative imaging of platinum-based antitumor complexes in bone tissue samples using LA-ICP-MS. Journal of Trace Elements in Medicine and Biology. 54. 98–102. 15 indexed citations

Nadar, Robin A., et al.. (2019). Thermoresponsive Brushes Facilitate Effective Reinforcement of Calcium Phosphate Cements. ACS Applied Materials & Interfaces. 11(30). 26690–26703. 12 indexed citations

Sedláček, Ondřej, et al.. (2017). Radiolabelled Polymeric Materials for Imaging and Treatment of Cancer: Quo Vadis?. Advanced Healthcare Materials. 6(6). 42 indexed citations

Nadar, Robin A., Nicola Margiotta, Michele Iafisco, et al.. (2017). Bisphosphonate‐Functionalized Imaging Agents, Anti‐Tumor Agents and Nanocarriers for Treatment of Bone Cancer. Advanced Healthcare Materials. 6(8). 41 indexed citations

10.

Sedláček, Ondřej, et al.. (2017). Theranostics: Radiolabelled Polymeric Materials for Imaging and Treatment of Cancer: Quo Vadis? (Adv. Healthcare Mater. 6/2017). Advanced Healthcare Materials. 6(6). 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact